185 related articles for article (PubMed ID: 24054724)
1. A case of oligodendroglioma with prominent neuronal differentiation.
Hirose T; Nobusawa S; Nakazato Y; Sasaki A
Hum Pathol; 2013 Oct; 44(10):2353-9. PubMed ID: 24054724
[TBL] [Abstract][Full Text] [Related]
2. Olig2 is useful in the differential diagnosis of oligodendrogliomas and extraventricular neurocytomas.
Okada M; Yano H; Hirose Y; Nakayama N; Ohe N; Shinoda J; Iwama T
Brain Tumor Pathol; 2011 Apr; 28(2):157-61. PubMed ID: 21312066
[TBL] [Abstract][Full Text] [Related]
3. Challenging diagnosis: oligodendroglioma versus extraventricular neurocytoma.
Mut M; Güler-Tezel G; Lopes MB; Bilginer B; Ziyal I; Ozcan OE
Clin Neuropathol; 2005; 24(5):225-9. PubMed ID: 16167546
[TBL] [Abstract][Full Text] [Related]
4. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
Preusser M; Budka H; Rössler K; Hainfellner JA
Histopathology; 2007 Feb; 50(3):365-70. PubMed ID: 17257132
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of NeuN immunoreactivity in primary brain tumours: conclusions for rational use in diagnostic histopathology.
Preusser M; Laggner U; Haberler C; Heinzl H; Budka H; Hainfellner JA
Histopathology; 2006 Mar; 48(4):438-44. PubMed ID: 16487366
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic oligodendroglioma with ganglioglioma-like maturation.
Tanaka Y; Nobusawa S; Yagi S; Ikota H; Yokoo H; Nakazato Y
Brain Tumor Pathol; 2012 Oct; 29(4):221-8. PubMed ID: 22231405
[TBL] [Abstract][Full Text] [Related]
7. Sarcomatous evolution of oligodendroglioma ("oligosarcoma"): confirmatory report of an uncommon pattern of malignant progression in oligodendroglial tumors.
Vajtai I; Vassella E; Hewer E; Kappeler A; Reinert MM
Pathol Res Pract; 2012 Dec; 208(12):750-5. PubMed ID: 23102810
[TBL] [Abstract][Full Text] [Related]
8. Cerebral neurocytoma without ganglion cell differentiation.
Kim JH; Park KJ; Lee JH; Chung HS
Acta Neurochir (Wien); 2005 Mar; 147(3):309-12; discussion 312. PubMed ID: 15618993
[TBL] [Abstract][Full Text] [Related]
9. Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications.
Perry A; Scheithauer BW; Macaulay RJ; Raffel C; Roth KA; Kros JM
J Neuropathol Exp Neurol; 2002 Nov; 61(11):947-55. PubMed ID: 12430711
[TBL] [Abstract][Full Text] [Related]
10. Extraventricular neurocytoma in a child mimicking oligodendroglioma: a diagnostic pitfall.
Limaiem F; Bellil S; Chelly I; Mekni A; Bellil K; Jemel H; Haouet S; Zitouna M; Kchir N
Pathologica; 2009 Apr; 101(2):105-7. PubMed ID: 19886559
[TBL] [Abstract][Full Text] [Related]
11. Oligodendroglial tumors with marked desmoplasia: clinicopathologic and molecular features of 7 cases.
Jentoft M; Giannini C; Rossi S; Mota R; Jenkins RB; Rodriguez FJ
Am J Surg Pathol; 2011 Jun; 35(6):845-52. PubMed ID: 21552114
[TBL] [Abstract][Full Text] [Related]
12. Atypical extraventricular neurocytoma.
Moriguchi S; Yamashita A; Marutsuka K; Yoneyama T; Nakano S; Wakisaka S; Nabeshima K; Asada Y
Pathol Int; 2006 Jan; 56(1):25-9. PubMed ID: 16398676
[TBL] [Abstract][Full Text] [Related]
13. Atypical extraventricular neurocytoma with oligodendroglioma-like spread and an unusual pattern of chromosome 1p and 19q loss.
Mrak RE; Yasargil MG; Mohapatra G; Earel J; Louis DN
Hum Pathol; 2004 Sep; 35(9):1156-9. PubMed ID: 15343519
[TBL] [Abstract][Full Text] [Related]
14. Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity.
Rodriguez FJ; Perry A; Rosenblum MK; Krawitz S; Cohen KJ; Lin D; Mosier S; Lin MT; Eberhart CG; Burger PC
Acta Neuropathol; 2012 Nov; 124(5):627-41. PubMed ID: 22941225
[TBL] [Abstract][Full Text] [Related]
15. Neuronal nuclear antigen (NeuN): a new tool in the diagnosis of central neurocytoma.
Soylemezoglu F; Onder S; Tezel GG; Berker M
Pathol Res Pract; 2003; 199(7):463-8. PubMed ID: 14521262
[TBL] [Abstract][Full Text] [Related]
16. Ki-67 and MCM6 labeling indices are correlated with overall survival in anaplastic oligodendroglioma, IDH1-mutant and 1p/19q-codeleted: a multicenter study from the French POLA network.
Pouget C; Hergalant S; Lardenois E; Lacomme S; Houlgatte R; Carpentier C; Dehais C; Rech F; Taillandier L; Sanson M; Appay R; Colin C; Figarella-Branger D; Battaglia-Hsu SF; Gauchotte G
Brain Pathol; 2020 May; 30(3):465-478. PubMed ID: 31561286
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of oligodendrogliomas expressing a mutant isocitrate dehydrogenase-1.
Thirant C; Varlet P; Lipecka J; Le Gall M; Broussard C; Chafey P; Studler JM; Lacombe J; Lions S; Guillaudeau A; Camoin L; Daumas-Duport C; Junier MP; Chneiweiss H
Proteomics; 2011 Nov; 11(21):4139-54. PubMed ID: 21898821
[TBL] [Abstract][Full Text] [Related]
18. Sarcoma-like tumor originating from oligodendroglioma.
Shoji T; Saito R; Kanamori M; Sonoda Y; Watanabe M; Tominaga T
Brain Tumor Pathol; 2016 Oct; 33(4):255-260. PubMed ID: 27333891
[TBL] [Abstract][Full Text] [Related]
19. Oligodendroglioma showing pleomorphic xanthoastrocytoma-like perivascular microlesion: With IDH1, TERT promoter mutation and 1p/19q codeletion detected in both components.
Murakami C; Ikota H; Nobusawa S; Nakata S; Yamazaki T; Hashiba Y; Hirato J; Yokoo H
Pathol Int; 2020 Jan; 70(1):40-46. PubMed ID: 31855307
[TBL] [Abstract][Full Text] [Related]
20. From glioblastoma to gangliocytoma: an unforeseen but welcome shift in biological behavior.
Jeibmann A; Hasselblatt M; Pfister S; Sträter R; Brentrup A; Holling M; Niederstadt T; Paulus W; Frühwald MC
J Neurosurg Pediatr; 2009 Nov; 4(5):475-8. PubMed ID: 19877783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
